1. LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement. Issue 9 (14th February 2020) Authors: Sastry, Namratha G; Wan, Xuechao; Huang, Tianzhi; Alvarez, Angel A; Pangeni, Rajendra P; Song, Xiao; James, Charles David; Horbinski, Craig M; Brennan, Cameron W; Nakano, Ichiro; Hu, Bo; Cheng, Shi-Yuan Journal: Neuro-oncology Issue: Volume 22:Issue 9(2020) Page Start: 1315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗